TheraV
PrivateLast Round
Grant
Dec 16, 2021
Total Funding Raised
$167,000
Company Overview
TheraV operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a Grant round in December 2021.
TheraV is a therapeutic devices company that develops wearable products using vibration technology to help amputees manage phantom limb pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraV Comparables
Compare TheraV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avanos Medical | 61% | |
| Lifeward Ltd. | 59% | |
| RxFunction | 59% |
For institutional investors. Book with your work email.
TheraV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2021 | ||||
| Accelerator | Sep 9, 2021 | ||||
| Grant | Jun 8, 2021 | ||||
| Grant | Mar 1, 2019 | ||||
| Grant | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TheraV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Delaware Division of Small Business | Grant |
| WomensNet | Grant |
| Startup Bucks | Accelerator |
| Horn Entrepreneurship | Grant |
| JPMorgan Chase & Co. | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2025
Monthly visitors increased 444% MoM, reaching 1.8K.
- Dec 16, 2021
$100K grant received from Delaware Division of Small Business.
For institutional investors. Book with your work email.
TheraV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TheraV's valuation, stock price, and market status.
Is TheraV a public or private company?
TheraV is a private company.
What is the current stock price of TheraV?
TheraV is a private company, so its shares have no public market price. Caplight tracks TheraV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheraV worth (valuation)?
Valuation information for TheraV is not publicly available.
Can I buy TheraV stock?
TheraV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheraV's last funding round?
TheraV's most recent funding round was Grant on December 16, 2021.
Who are the main investors in TheraV?
Key investors in TheraV include Delaware Division of Small Business, WomensNet, Startup Bucks, Horn Entrepreneurship, JPMorgan Chase & Co..
Will TheraV IPO soon?
No public IPO plans have been announced for TheraV.
How can I track TheraV secondary market activity?
Caplight tracks bids, offers, and trades in TheraV's shares on secondary markets.